Rational Discovery of BACE1‐Selective Inhibitors as Potential Therapeutics for Alzheimer's Disease

Documenti analoghi

• Management of Alzheimer's Disease With Nanotechnological Interventions and Novel Therapeutics
  di: Mohd Shahrukh, et al.
  Pubblicazione: (2025)
• Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ b ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLC
  di: Mohamed K. Elgohary, et al.
  Pubblicazione: (2025)
• Discovery of Novel 1,3,5‐trisubstituted‐2‐thioxo‐imidazole Derivatives as Potential Aromatase Inhibitors: Design, Synthesis, In Vitro Anti‐Breast Cancer Screening and Molecular Docking Studies
  di: Mohamed F. Youssef, et al.
  Pubblicazione: (2026)
• Discovery of Novel SIRT3 Inhibitors for the Cancer Differentiation Therapy by Structural Modification
  di: Honggang Li, et al.
  Pubblicazione: (2024)
• Reduced Taurine Transporter Expression in Lymphoblastoid Cell Lines From Alzheimer's Disease Patients Compared With Age‐Matched Controls: Therapeutic Implications?
  di: Yuval Gavriel, et al.
  Pubblicazione: (2025)